Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 20;23(1):336.
doi: 10.1186/s12882-022-02969-3.

Unmet needs about iron deficiency in peritoneal dialysis: a Delphi consensus panel

Sandro Mazzaferro  1 , Silvia D'Alonzo  2 , Massimo Morosetti  3
Affiliations

Unmet needs about iron deficiency in peritoneal dialysis: a Delphi consensus panel

Sandro Mazzaferro et al. BMC Nephrol. .

Abstract

Background: Anaemia and iron deficiency (ID) are common in chronic kidney disease (CKD) patients and related to outcomes. There is growing interest about the role of iron supplementation in CKD, particularly ferric carboxymaltose (FCM), also in relation to the use of erythropoiesis stimulating agents (ESAs). Despite a greater knowledge on ID management in patients receiving haemodialysis, a paucity of data exists about peritoneal dialysis (PD). Furthermore, the aim of this paper is to provide the results of a nationwide Italian survey about ID in PD using the Delphi method.

Methods: A list of 16 statements (48 items) was developed about four main topics: (1) approach to iron therapy in PD; (2) management experience about iron therapy in PD; (3) ESA and iron in PD; (4) pharmacoeconomic impact. Using the Delphi methodology, the survey was distributed online to 36 Italian nephrologists with expertise in PD, who rated their level of agreement with each item on a 5-point Likert scale. Consensus was predefined as more than 66% of the panel agreeing/disagreeing with any given statement.

Results: Twenty-five experts (70%) answered the survey. 35 items (73%) achieved a consensus (8 negative and 27 positive). In particular, the diagnosis of ID is widely known, but some doubts exist about how frequently test it. The use of I.V. iron seems to be routinary and can save money reducing the administration of ESAs. However, internal protocols are welcome.

Conclusions: Expert PD nephrologists know well the problem of ID and feel the necessity of shared protocols to optimize the iron therapy and consequently the use of ESAs.

Keywords: Anaemia; Chronic kidney disease; Ferric carboxymaltose; Iron deficiency; Peritoneal dialysis.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
National distribution of respondents
See this image and copyright information in PMC

References

    1. KDIGO Anemia Work Group KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int Suppl. 2012;2:279–335.
    1. Atkinson MA, Warady BA. Anemia in chronic kidney disease. Pediatr Nephrol. 2018;33:227–238. doi: 10.1007/s00467-017-3663-y. - DOI - PubMed
    1. Babitt JL, Lin HY. Mechanisms of anemia in CKD. J Am Soc Nephrol. 2012;23:1631–1634. doi: 10.1681/ASN.2011111078. - DOI - PMC - PubMed
    1. Gafter-Gvili A, Schechter A, Rozen-Zvi B. Iron Deficiency Anemia in Chronic Kidney Disease. Acta Haematol. 2019;142:44–50. doi: 10.1159/000496492. - DOI - PubMed
    1. Locatelli F, Mazzaferro S, Yee J. Iron Therapy Challenges for the Treatment of Nondialysis CKD Patients. Clin J Am Soc Nephrol. 2016;11:1269–1280. doi: 10.2215/CJN.00080116. - DOI - PMC - PubMed

Publication types